180 related articles for article (PubMed ID: 17525212)
21. Cancer stem cell characteristics in retinoblastoma.
Seigel GM; Campbell LM; Narayan M; Gonzalez-Fernandez F
Mol Vis; 2005 Sep; 11():729-37. PubMed ID: 16179903
[TBL] [Abstract][Full Text] [Related]
22. Antitumor activity of TMPyP4 interacting G-quadruplex in retinoblastoma cell lines.
Mikami-Terao Y; Akiyama M; Yuza Y; Yanagisawa T; Yamada O; Kawano T; Agawa M; Ida H; Yamada H
Exp Eye Res; 2009 Aug; 89(2):200-8. PubMed ID: 19328784
[TBL] [Abstract][Full Text] [Related]
23. Artesunate exerts specific cytotoxicity in retinoblastoma cells via CD71.
Zhao F; Wang H; Kunda P; Chen X; Liu QL; Liu T
Oncol Rep; 2013 Sep; 30(3):1473-82. PubMed ID: 23818062
[TBL] [Abstract][Full Text] [Related]
24. Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma.
Tsui JY; Dalgard C; Van Quill KR; Lee L; Grossniklaus HE; Edelhauser HF; O'Brien JM
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):490-6. PubMed ID: 18234990
[TBL] [Abstract][Full Text] [Related]
25. Synergistic Effect of Curcumin in Combination with Anticancer Agents in Human Retinoblastoma Cancer Cell Lines.
Sreenivasan S; Krishnakumar S
Curr Eye Res; 2015; 40(11):1153-65. PubMed ID: 25495096
[TBL] [Abstract][Full Text] [Related]
26. Missing expression of pRb2/p130 in human retinoblastomas is associated with reduced apoptosis and lesser differentiation.
Bellan C; De Falco G; Tosi GM; Lazzi S; Ferrari F; Morbini G; Bartolomei S; Toti P; Mangiavacchi P; Cevenini G; Trimarchi C; Cinti C; Giordano A; Leoncini L; Tosi P; Cottier H
Invest Ophthalmol Vis Sci; 2002 Dec; 43(12):3602-8. PubMed ID: 12454024
[TBL] [Abstract][Full Text] [Related]
27. The NK-1 receptor antagonist L-732,138 induces apoptosis in human gastrointestinal cancer cell lines.
Muñoz M; Rosso M; Coveñas R
Pharmacol Rep; 2017 Aug; 69(4):696-701. PubMed ID: 28550801
[TBL] [Abstract][Full Text] [Related]
28. The effect of a selective cyclooxygenase-2 (COX-2) inhibitor on the proliferation rate of retinoblastoma cell lines.
de Souza Filho JP; Correa ZM; Marshall JC; Anteka E; Coutinho AB; Martins MC; Burnier MN
Eye (Lond); 2006 May; 20(5):598-601. PubMed ID: 16123787
[TBL] [Abstract][Full Text] [Related]
29. Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications.
Poulaki V; Mitsiades CS; Kotoula V; Negri J; McMullan C; Miller JW; Marks PA; Mitsiades N
Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4072-9. PubMed ID: 19387079
[TBL] [Abstract][Full Text] [Related]
30. Involvement of interleukin-1beta-converting enzyme in apoptosis of irradiated retinoblastomas.
Kondo Y; Liu J; Haqqi T; Barna BP; Kondo S
Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2769-74. PubMed ID: 9856788
[TBL] [Abstract][Full Text] [Related]
31. Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines.
Kashiwagi Y; Horie K; Kanno C; Inomata M; Imamura T; Kato M; Yamamoto T; Yamashita H
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):679-85. PubMed ID: 19737884
[TBL] [Abstract][Full Text] [Related]
32. Expression of glutamate transporter subtypes in cultured retinal pigment epithelial and retinoblastoma cells.
Mäenpää H; Gegelashvili G; Tähti H
Curr Eye Res; 2004 Mar; 28(3):159-65. PubMed ID: 14977517
[TBL] [Abstract][Full Text] [Related]
33. Neurokinin-1 receptor: a new promising target in the treatment of cancer.
Muñoz M; Coveñas R
Discov Med; 2010 Oct; 10(53):305-13. PubMed ID: 21034671
[TBL] [Abstract][Full Text] [Related]
34. NK-1 receptor antagonists as antitumor drugs: a survey of the literature from 2000 to 2011.
Muñoz M; Martinez-Armesto J; Coveñas R
Expert Opin Ther Pat; 2012 Jul; 22(7):735-46. PubMed ID: 22697287
[TBL] [Abstract][Full Text] [Related]
35. A ligand-receptor pair that triggers a non-apoptotic form of programmed cell death.
Castro-Obregón S; Del Rio G; Chen SF; Swanson RA; Frankowski H; Rao RV; Stoka V; Vesce S; Nicholls DG; Bredesen DE
Cell Death Differ; 2002 Aug; 9(8):807-17. PubMed ID: 12107824
[TBL] [Abstract][Full Text] [Related]
36. Antitumor activity of arsenic trioxide on retinoblastoma: cell differentiation and apoptosis depending on arsenic trioxide concentration.
Kim JH; Kim JH; Yu YS; Kim DH; Kim CJ; Kim KW
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1819-23. PubMed ID: 19060284
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the interaction of diacylpiperazine antagonists with the human neurokinin-1 receptor: identification of a common binding site for structurally dissimilar antagonists.
Cascieri MA; Shiao LL; Mills SG; MacCoss M; Swain CJ; Yu H; Ber E; Sadowski S; Wu MT; Strader CD
Mol Pharmacol; 1995 Apr; 47(4):660-5. PubMed ID: 7536886
[TBL] [Abstract][Full Text] [Related]
38. Reversal of stathmin-mediated microtubule destabilization sensitizes retinoblastoma cells to a low dose of antimicrotubule agents: a novel synergistic therapeutic intervention.
Mitra M; Kandalam M; Sundaram CS; Verma RS; Maheswari UK; Swaminathan S; Krishnakumar S
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5441-8. PubMed ID: 21546534
[TBL] [Abstract][Full Text] [Related]
39. The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drug.
Muñoz M; Rosso M
Invest New Drugs; 2010 Apr; 28(2):187-93. PubMed ID: 19148578
[TBL] [Abstract][Full Text] [Related]
40. Retinoic acid upregulates cone arrestin expression in retinoblastoma cells through a Cis element in the distal promoter region.
Li A; Zhu X; Craft CM
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1375-83. PubMed ID: 11980849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]